BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32914850)

  • 1. SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins.
    De Michele S; Remotti HE; Del Portillo A; Lagana SM; Szabolcs M; Saqi A
    Am J Clin Pathol; 2021 Jan; 155(1):124-132. PubMed ID: 32914850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
    Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
    J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas.
    Zhang YJ; Chen JW; He XS; Zhang HZ; Ling YH; Wen JH; Deng WH; Li P; Yun JP; Xie D; Cai MY
    EBioMedicine; 2018 Feb; 28():62-69. PubMed ID: 29396302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas.
    Kim CJ; Baruch-Oren T; Lin F; Fan XS; Yang XJ; Wang HL
    J Clin Pathol; 2016 Dec; 69(12):1046-1050. PubMed ID: 27169755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
    Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of SATB2 expression in colon cancer and its differential diagnosis in digestive tract adenocarcinoma and ovarian primary and metastatic carcinoma.
    Liu F; Gao Z; Shen D; Zhao H; Wang C; Ye Y; Ma Y; Kong F
    Pathol Res Pract; 2019 Jul; 215(7):152430. PubMed ID: 31101576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
    Aldaoud N; Erashdi M; AlKhatib S; Abdo N; Al-Mohtaseb A; Graboski-Bauer A
    BMC Res Notes; 2019 Nov; 12(1):770. PubMed ID: 31771640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
    Mounajjed T; Zhang L; Wu TT
    Hum Pathol; 2013 Apr; 44(4):542-50. PubMed ID: 23079207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Immunophenotypic Panel to Differentiate Upper From Lower Gastrointestinal Adenocarcinomas: Analysis of New and Traditional Markers.
    Chauhan A; Sanchez-Avila M; Manivel J; Dachel S; Larson W; Hanson B; Gravely A; Mesa H
    Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):13-19. PubMed ID: 33295746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
    Magnusson K; de Wit M; Brennan DJ; Johnson LB; McGee SF; Lundberg E; Naicker K; Klinger R; Kampf C; Asplund A; Wester K; Gry M; Bjartell A; Gallagher WM; Rexhepaj E; Kilpinen S; Kallioniemi OP; Belt E; Goos J; Meijer G; Birgisson H; Glimelius B; Borrebaeck CA; Navani S; Uhlén M; O'Connor DP; Jirström K; Pontén F
    Am J Surg Pathol; 2011 Jul; 35(7):937-48. PubMed ID: 21677534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S; Parra-Herran C
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.
    Ma C; Olevian DC; Lowenthal BM; Jayachandran P; Kozak MM; Chang DT; Pai RK
    Am J Surg Pathol; 2018 Oct; 42(10):1409-1417. PubMed ID: 30001238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
    Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
    Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Evaluation of Special AT-rich Sequence-binding Protein 2 (SATB2) Immunohistochemical Staining in Mucinous Tumors From Gastrointestinal and Nongastrointestinal Sites.
    Ramos BD; Brettfeld S; Berry RS; Routh JK; Martin DR; Hanson JA
    Appl Immunohistochem Mol Morphol; 2019; 27(5):378-385. PubMed ID: 29271791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Stain With SATB2 and CK20/Villin Is Useful to Distinguish Colorectal Carcinomas From Other Tumors.
    Li Z; Rock JB; Roth R; Lehman A; Marsh WL; Suarez A; Frankel WL
    Am J Clin Pathol; 2018 Feb; 149(3):241-246. PubMed ID: 29471325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.